GBGB2005520.8A
GB202005520D0
(en)
|
2020-04-16 |
2020-04-16 |
Elastase inhibition
|
PCT/GB2021/050658
WO2021209740A1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection
|
EP21714345.2A
EP4106757B1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
SI202130071T
SI4106757T1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
HUE21714345A
HUE064089T2
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
PCT/GB2021/050653
WO2021209739A1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
ES21714345T
ES2962498T3
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving the neutrophil elastase inhibitor alvelestat for the treatment of respiratory diseases mediated by alpha-1 antitrypsin deficiency
|
US17/995,908
US20230218596A1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection
|
AU2021256835A
AU2021256835A1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
HRP20231065TT
HRP20231065T1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
LTEPPCT/GB2021/050653T
LT4106757T
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
EP23187058.5A
EP4252850A3
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
PL21714345.2T
PL4106757T3
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
US17/995,909
US20230190723A1
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
PT217143452T
PT4106757T
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
MX2022012942A
MX2022012942A
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency.
|
FIEP21714345.2T
FI4106757T3
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
IL297211A
IL297211A
(en)
|
2020-04-16 |
2021-03-16 |
Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
|
JP2022562608A
JP2023522010A
(en)
|
2020-04-16 |
2021-03-16 |
Methods Relating to the Neutrophil Elastase Inhibitor Alberestat for the Treatment of Respiratory Diseases Mediated by Deficiency of α1-Antitrypsin
|
DK21714345.2T
DK4106757T3
(en)
|
2020-04-16 |
2021-03-16 |
METHODS INVOLVING THE NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR THE TREATMENT OF AIRWAY DISEASE MEDIATED BY ALPHA-1-ANTITRYPSIN DEFICIENCY
|